The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant candida albicans

Nathan P. Wiederhold, Laura K. Najvar, Annette W. Fothergill, Dora I. McCarthy, Rosie Bocanegra, Marcos Olivo, William R. Kirkpatrick, Michael P. Everson, Frederick P. Duncanson, Thomas F. Pattersona

Producción científica: Articlerevisión exhaustiva

50 Citas (Scopus)

Resumen

The in vitro and in vivo activity of the inositol acyltransferase inhibitor E1210 was evaluated against echinocandin-resistant Candida albicans. E1210 demonstrated potent in vitro activity, and in mice with invasive candidiasis caused by echinocandinresistant C. albicans, oral doses of 10 and 40 mg E1210/kg of body weight twice daily significantly improved survival and reduced fungal burden compared to those of controls and mice treated with caspofungin (10 mg/kg/day). These results demonstrate the potential use of E1210 against resistant C. albicans infections.

Idioma originalEnglish (US)
Páginas (desde-hasta)690-692
Número de páginas3
PublicaciónAntimicrobial agents and chemotherapy
Volumen59
N.º1
DOI
EstadoPublished - ene 1 2015

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Huella

Profundice en los temas de investigación de 'The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant candida albicans'. En conjunto forman una huella única.

Citar esto